Document Type : Original Article

Authors

1 Medical Laboratory Technique Department, The Islamic University, Diwaniya, Iraq

2 Research and Studies Department, The Islamic University, Najaf, Iraq

10.55705/cmbr.2021.142761.1015

Abstract

Emerging antibiotic resistance in microorganisms particularly multidrug-resistant strains among bacteria are increasing because of misusing antibiotics as well as evolution of antibiotic resistance mechanisms. In this regard, Acinetobacter baumannii is one of the six most common multidrug-resistant microorganisms in hospitals. Recently, carbapenems, as common antibiotics to treat infections of Acinetobacter have not an acceptable efficiency because of the resistance emergence to these antibiotics in many strains.  In this study, resistant strains of A. baumannii were isolated and identified as an appropriate preventive strategy to reduce infections in hospitals. Disc diffusion test and PCR method were used to isolate of resistant strains and identify beta-lactamase genes of blaAmpC, blaTEM, blaVIM, and blaSHV. This study showed that these genes were contributed in antibiotic resistance with about 18.4% and ≥53.5% strains expressing all 4 genes and ≥3 genes, respectively. The blaAmpC gene is more prevalent than other genes, and this is probably due to the prevalence or rapid transfer of this beta-lactamase. However, more studies should be performed in a comparative way to isolate and identify other antibiotic-resistant bacterial strains relate to other hospitals.

Graphical Abstract

Evaluation of antibiotic resistance and prevalence of multi-antibiotic resistant genes among Acinetobacter baumannii strains isolated from patients admitted to al-yarmouk hospital

Keywords

Main Subjects

Selected author of this article by journal

ِDr. Qassim hassan Aubais aljelehawy
The Islamic University

Researchgate ; Google Scholar

Open Access

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit: http://creativecommons.org/licenses/by/4.0/

 

Publisher’s Note

CMBR journal remains neutral with regard to jurisdictional claims in published maps and institutional afflictions.

 

Letters to Editor

Given that CMBR Journal's policy in accepting articles will be strict and will do its best to ensure that in addition to having the highest quality published articles, the published articles should have the least similarity (maximum 18%). Also, all the figures and tables in the article must be original and the copyright permission of images must be prepared by authors. However, some articles may have flaws and have passed the journal filter, which dear authors may find fault with. Therefore, the editor of the journal asks the authors, if they see an error in the published articles of the journal, to email the article information along with the documents to the journal office.

CMBR Journal welcomes letters to the editor ([email protected]) for the post-publication discussions and corrections which allows debate post publication on its site, through the Letters to Editor. Critical letters can be sent to the journal editor as soon as the article is online. Following points are to be considering before sending the letters (comments) to the editor.


[1] Letters that include statements of statistics, facts, research, or theories should include appropriate references, although more than three are discouraged.
[2] Letters that are personal attacks on an author rather than thoughtful criticism of the author’s ideas will not be considered for publication.
[3] There is no limit to the number of words in a letter.
[4] Letter writers should include a statement at the beginning of the letter stating that it is being submitted either for publication or not.

[5] Anonymous letters will not be considered.
[6] Letter writers must include Name, Email Address, Affiliation, mobile phone number, and Comments

[7] Letters will be answered as soon as possible

  1. Ercisli MF, Lechun G, Azeez SH, Hamasalih RM, Song S, Aziziaram Z (2021) Relevance of genetic polymorphisms of the human cytochrome P450 3A4 in rivaroxaban-treated patients. Cell Mol Biomed Rep 1(1):33-41
  2. Tourang M, Fang L, Zhong Y, Suthar RC (2021) Association between Human Endogenous Retrovirus K gene expression and breast cancer. Cell Mol Biomed Rep 1(1):7-13
  3. Alavi M, Webster TJ (2021) Recent progress and challenges for polymeric microsphere compared to nanosphere drug release systems: Is there a real difference? Bioorg Med Chem 33:116028. doi:https://doi.org/10.1016/j.bmc.2021.116028
  4. Aljelehawy Q, Karimi N, Alavi M (2020) Comparison of antibacterial and cytotoxic activities of phytosynthesized ZnONPs by leaves extract of Daphne mucronata at different salt sources. Mater Technol):1-13. doi:https://doi.org/10.1080/10667857.2020.1794280
  5. Li B, Webster TJ (2018) Bacteria antibiotic resistance: New challenges and opportunities for implant‐associated orthopedic infections. J Orthop Res 36(1):22-32. doi:http://doi.org/10.1002/jor.23656
  6. Alavi M, Rai M (2021) Chapter 11 - Antibacterial and wound healing activities of micro/nanocarriers based on carboxymethyl and quaternized chitosan derivatives. In: Rai M, dos Santos CA (eds) Biopolymer-Based Nano Films. Elsevier, pp 191-201. doi:https://doi.org/10.1016/B978-0-12-823381-8.00009-0
  7. Alavi M, Dehestaniathar S, Mohammadi S, Maleki A, Karimi N (2020) Antibacterial activities of phytofabricated ZnO and CuO NPs by Mentha pulegium leaf/flower mixture extract against antibiotic resistant bacteria. Adv Pharm Bull 1:1-14. doi:http://doi.org/10.34172/apb.2021.057
  8. Georgios M, Egki T, Effrosyni S (2014) Phenotypic and molecular methods for the detection of antibiotic resistance mechanisms in Gram negative nosocomial pathogens. Trends Infect Dis):139-162. doi:http://doi.org/10.5772/57582
  9. Ayoub Moubareck C, Hammoudi Halat D (2020) Insights into Acinetobacter baumannii: A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen. Antibiotics 9(3):119
  10. Bergogne-Bérézin E, Joly-Guillou ML, Towner KJ (2020) Introduction—History and Importance of Acinetobacter spp., Role in Infections, Treatment and Cost Implications. In: Acinetobacter. CRC Press, pp 1-12
  11. Chan P-C, Huang L-M, Lin H-C, Chang L-Y, Chen M-L, Lu C-Y, Lee P-I, Chen J-M, Lee C-Y, Pan H-J (2007) Control of an outbreak of pandrug-resistant Acinetobacter baumannii colonization and infection in a neonatal intensive care unit. Infect Control Hosp Epidemiol 28(4):423-429. doi:http://doi.org/10.1086/513120
  12. Kyriakidis I, Vasileiou E, Pana ZD, Tragiannidis A (2021) Acinetobacter baumannii Antibiotic Resistance Mechanisms. Pathogens 10(3):373. doi:http://doi.org/10.3390/pathogens10030373
  13. Bush K, Jacoby GA (2010) Updated functional classification of beta-lactamases. Antimicrob Agents Chemother 54(3):969-976. doi:http://doi.org/10.1128/AAC.01009-09
  14. Lee C-R, Lee JH, Park M, Park KS, Bae IK, Kim YB, Cha C-J, Jeong BC, Lee SH (2017) Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front Cell Infect Microbiol

 7:55. doi:http://doi.org/10.3389/fcimb.2017.00055

  1. Paterson DL, Bonomo RA (2005) Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 18(4):657-686. doi:http://doi.org/10.1128/CMR.18.4.657-686.2005
  2. Alavi M, Karimi N (2019) Biosynthesis of Ag and Cu NPs by secondary metabolites of usnic acid and thymol with biological macromolecules aggregation and antibacterial activities against multi drug resistant (MDR) bacteria. Int J Biol Macromol 128:893-901. doi:https://doi.org/10.1016/j.ijbiomac.2019.01.177
  3. Piperaki ET, Tzouvelekis LS, Miriagou V, Daikos GL (2019) Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment. Clin Microbiol Infect 25(8):951-957. doi:http://doi.org/10.1016/j.cmi.2019.03.014
  4. Leverstein-van Hall MA, Fluit AC, Paauw A, Box ATA, Brisse S, Verhoef J (2002) Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp. J Clin Microbiol 40(10):3703-3711. doi:http://doi.org/10.1128/JCM.40.10.3703-3711.2002
  5. Afhami S, Borumand MA, Bazzaz NE, Saffar H, Hadadi A, Nezhad MJ, Tirabadi NM (2020) Antimicrobial resistance pattern of Acinetobacter; a multicenter study, comparing European Committee on Antimicrobial Susceptibility Testing (EUCAST) and the Clinical and Laboratory Standards Institute (CLSI); evaluation of susceptibility testing methods for polymyxin. Immunopathol persa 7(1):e04-e04. doi:http://doi.org/10.34172/ipp.2021.04
  6. Andrzejczuk S, Kosikowska U, Chwiejczak E, Stępień-Pyśniak D, Malm A (2019) Prevalence of resistance to β-lactam antibiotics and bla genes among commensal Haemophilus parainfluenzae isolates from respiratory microbiota in Poland. Microorganisms 7(10):427
  7. Ahmed OB, Dablool AS (2017) Quality improvement of the DNA extracted by boiling method in gram negative bacteria. Int J Bioassays 6(4):5347-5349. doi:http://dx.doi.org/10.21746/ijbio.2017.04.004
  8. Chang Y, Luan G, Xu Y, Wang Y, Shen M, Zhang C, Zheng W, Huang J, Yang J, Jia X (2015) Characterization of carbapenem-resistant Acinetobacter baumannii isolates in a Chinese teaching hospital. Front Microbiol 6:910. doi:http://doi.org/10.3389/fmicb.2015.00910
  9. Lowings M, Ehlers MM, Dreyer AW, Kock MM (2015) High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa–an update. BMC Infect Dis 15(1):1-10. doi:http://doi.org/10.1186/s12879-015-1246-8
  10. Yin X-L, Hou T-W, Xu S-B, Ma C-Q, Yao Z-Y, Li W, Wei L (2008) Detection of drug resistance–associated genes of multidrug-resistant Acinetobacter baumannii. Microb Drug Resist 14(2):145-150. doi:http://doi.org/10.1089/mdr.2008.0799
  11. Mohammed H, Elsadek Fakhr A, Al Johery SaE, Abdel Ghani Hassanein W (2016) Spread of TEM, VIM, SHV, and CTX-M β-lactamases in imipenem-resistant Gram-negative bacilli isolated from Egyptian hospitals. Int J Microbiol 2016. doi:http://doi.org/10.1155/2016/8382605
  12. Shali AAK (2012) Identification of Multidrug-Resistant Genes in" Acinetobacter baumannii" in Sulaimani City-Kurdistan Regional Government of Iraq. Asian J Med Sci 4(5):179-183
  13. Al-Hasnawy HH, Saleh RH, Hadi BH (2018) Existence ofaESBL genes in Escherichia coli and Acinetobacter baumannii isolated from different clinical specimens. J Pharm Sci 10(5):1112-1117. doi:https://www.jpsr.pharmainfo.in/issue.php?page=105#
  14. Aziz RAR, Al-Jubori SS (2017) Molecular analysis of genetic elements responsible for XDR in highly successful pathogen Acinetobacter baumannii isolated from clinical samples of Iraqi patients. J Glob Pharma Technol 9(4):26-39. doi:http://www.jgpt.co.in/index.php/jgpt/issue/archive?issuesPage=4#issues
  15. Al-Agamy MH, Khalaf NG, Tawfick MM, Shibl AM, El Kholy A (2014) Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt. Int J Infect Dis 22:49-54. doi:https://doi.org/10.1016/j.ijid.2013.12.004
  16. Mushi MF, Mshana SE, Imirzalioglu C, Bwanga F (2014) Carbapenemase genes among multidrug resistant gram negative clinical isolates from a tertiary hospital in Mwanza, Tanzania. Biomed Res Int 2014. doi:https://doi.org/10.1155/2014/303104
  17. Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, Ecker DJ, Massire C, Eshoo MW, Sampath R (2006) Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother 50(12):4114-4123. doi:http://doi.org/10.1128/AAC.00778-06
  18. Fallah F, Noori M, Hashemi A, Goudarzi H, Karimi A, Erfanimanesh S, Alimehr S (2014) Prevalence of blaNDM, blaPER, blaVEB, blaIMP, and blaVIM genes among Acinetobacter baumannii isolated from two hospitals of Tehran, Iran. Scientifica 2014. doi:http://doi.org/10.1155/2014/245162
  19. Al-Kadmy IMS, Ali ANM, Salman IMA, Khazaal SS (2018) Molecular characterization of Acinetobacter baumannii isolated from Iraqi hospital environment. New Microbes New Infect 21:51-57. doi:https://doi.org/10.1016/j.nmni.2017.10.010